X
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ARIPIPRAZOLE, with a corresponding US DMF Number 20189.
Remarkably, this DMF maintains an Inactive status since its submission on July 16, 2007, highlighting commitment to regulatory compliance.